Skip to main content

Table 1 Samples of human post-mortem temporal cortex (BA21) used for this research, including UK Brain Bank Identification Number (UK BBN ID), and anonymised demographics of the cases studied including Braak neurofibrillary tangle stage and APOE genotype, as reported by the SWDBB brain bank

From: Cathepsin B abundance, activity and microglial localisation in Alzheimer’s disease-Down syndrome and early onset Alzheimer’s disease; the role of elevated cystatin B

UK BBN ID

Gender

Age at death (years)

PMI (hours)

APOE

Status

Braak

BBN_9061

F

54

24

3,3

AD

VI

BBN_9162

M

63

43

3,3

AD

VI

BBN_9212

F

65

22

3,3

AD

VI

BBN_9259

F

47

54

3,4

AD

VI

BBN_9265

F

60

5

2,3

AD

VI

BBN_9291

M

62

25

3,4

AD

VI

BBN_9315

F

67

24

4,4

AD

VI

BBN_9342

F

65

12

4,4

AD

VI

BBN_4202

M

64

67

4,4

AD

V

BBN_9406

M

61

33

2,3

AD

VI

BBN_8761

M

63

31

3,3

DS-AD

n/a

BBN_8867

M

62

24

3,4

DS-AD

VI

BBN_8869

M

62

51

3,3

DS-AD

V

BBN_8881

F

63

51

2,3

DS-AD

VI

BBN_8887

F

50

43

3,4

DS-AD

VI

BBN_8953

F

64

48

3,3

DS-AD

VI

BBN_8991

M

64

16

3,3

DS-AD

V

BBN_8994

F

59

24

3,3

DS-AD

VI

BBN_9097

F

67

17

3,4

DS-AD

VI

BBN_9184

F

48

79

2,4

DS-AD

IV

BBN_8696

M

63

40

3,3

Healthy-ageing

 

BBN_8700

M

64

12

3,4

Healthy-ageing

 

BBN_8702

M

58

20

2,3

Healthy-ageing

 

BBN_8703

M

64

16

3,3

Healthy-ageing

 

BBN_8835

F

73

59

3,3

Healthy-ageing

 

BBN_8980

F

72

24

3,3

Healthy-ageing

 

BBN_9389

F

68

39

2,3

Healthy-ageing

0

BBN_9399

F

73

50

3,4

Healthy-ageing

II

BBN_9422

F

74

40

3,3

Healthy-ageing

I

BBN_9432

F

74

28

N/A

Healthy-ageing

II